Psych News Alert | antipsychotic

LAI Antipsychotics Associated With Diminishing Risk of Relapse but Risk Remains High

2/20/25 12:00 AM

Formulary Restrictions for LAI Antipsychotics Are Infrequent in Medicare

2/6/25 12:00 AM

Study Finds Clozapine Is Most Effective Option for Preventing Second Psychosis Relapse

1/24/25 12:00 AM

Reviewing the FDA’s Major Psychiatry Approvals in 2024

12/27/24 12:00 AM

New Schizophrenia Drug Shows Marked Effect on Cognitive Deficits

12/11/24 12:00 AM

Many Patients With Schizophrenia Benefit From Guided Antipsychotic Tapering Program

10/22/24 12:00 AM

Living Situation of People With ID Does Not Appear to Influence Antipsychotic Prescribing Decisions

10/11/24 12:00 AM

FDA Approves Cobenfy, Antipsychotic With a New Approach to Schizophrenia

9/27/24 12:00 AM

Researchers Propose Olanzapine and Perphenazine as First-Line Schizophrenia Treatments

9/6/24 12:00 AM